Adult asthma affects more than 25 million Americans, yet many sufferers unknowingly engage in daily practices that exacerbate their condition. Unlike childhood asthma, which often receives immediate ...

An asthma self-management app paired with wearables improved asthma control for adults in a randomized controlled trial. African American patients gained less from the digital intervention. The study ...

In adults with asthma, a digital asthma self-management (DASM) program improved symptom control compared with usual care, although its effectiveness varied by race, with weaker results observed among ...

Please provide your email address to receive an email when new articles are posted on . Data were derived from Silberman J, et al. JAMA Netw Open. 2025;doi:10.1001 ...

Omalizumab, alone or with allergen immunotherapy for house dust mites, may reduce daily use of inhaled corticosteroids in patients with house dust mite-sensitized mild-to-moderate allergic asthma.

Tezspire (tezepelumab-ekko) is a monthly injection used to treat severe asthma. It was approved by the FDA in 2021 for use in addition to other asthma controlling medicines in people 12 and older.

A peak flow meter is a simple, small, hand-held tool that can help you maintain control of asthma by providing a measurement of how well air moves out of the lungs. After blowing into the device, the ...

Please provide your email address to receive an email when new articles are posted on . Maternal asthma raises the risk for various perinatal complications. Asthma exacerbations during pregnancy are ...

Add Yahoo as a preferred source to see more of our stories on Google. Weight-loss jabs like Ozempic/Wegovy have been touted as miracle drugs revolutionizing how obesity is treated. Steffen Trumpf/dpa ...

Washington, DC, Feb. 04, 2026 (GLOBE NEWSWIRE) -- The Asthma and Allergy Foundation of America (AAFA) applauds Congress for protecting $33.5 million in funding for the Centers for Disease Control and ...

An asthma self-management app paired with wearables improved asthma control for adults in a randomized controlled trial. The primary efficacy outcome among the 550 participants with initially ...